Wedbush Reiterates Outperform Rating on Blueprint Medicines (BPMC), Adds to Best Idea List
Go back to Wedbush Reiterates Outperform Rating on Blueprint Medicines (BPMC), Adds to Best Idea List| (NASDAQ: BPMC) | Delayed: 90.73 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $90.73 | 52 Week High | $35.96 | |||
| Open | $90.73 | 52 Week Low | $13.04 | |||
| Day High | $90.73 | P/E | N/A | |||
| Day Low | $90.73 | EPS | $0.00 | |||
| Volume | 1,579 | |||||
